Navigation Links
d’Oliveira & Associates Releases New Webpage on Pradaxa Lawsuits
Date:3/6/2013

(PRWEB) March 06, 2013

Manufactured by Boehringer Ingelheim, Pradaxa is an anticoagulant drug that is used to treat a variety of blood and heart conditions*. In October 2010, the Food and Drug Administration (FDA) approved Pradaxa for sale on the market*. As reported by the NY Times, Pradaxa was marketed as a superior drug choice to Warfarin, but medical studies suggest that Pradaxa may be more dangerous than Warfarin*. The NY Times article goes on to explain that excessive bleeding from Warfarin can treated with Vitamin K, but the anticoagulant drug Pradaxa has no such treatment to counteract excessive bleeding*. The FDA lists the Pradaxa side effects that may include nosebleeds, discolored urine and stool, unusual hemorrhaging, headaches, and swelling**. More serious medical conditions linked to Pradaxa may include heart attack, stroke, and even death**. The USA Today reports the FDA has received over 3,781 reports of unfavorable Pradaxa side effects, which include about alleged 2,400 hemorrhages, 291 cases of acute renal failure, 640 strokes, and 542 deaths***.

Sources:
*http://www.nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html?_r=0
**http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***usatoday30.usatoday.com/news/health/story/2012-08-19/pradaxa-blood-thinner-lawsuit/57134628/1

Pradaxa lawsuits have alleged the drug contained inadequate warnings, which did not fairly apprise patients of the serious health risks associated with the drug*. Pradaxa’s manufacturer, Boehringer Ingelheim, also faces wrongful death claims and on August 8, 2012, Pradaxa lawsuits were consolidated in the United States District Court for the Southern District of Illinois (MDL-2385)*. Over 150 cases with 165 plaintiffs have been included in this Pradaxa Multidistrict Litigation*. Recently, the judge overseeing this litigation issued an order requiring Boehringer Ingelheim to produce “Paper and Pradaxa-Specific Electronic Custodial files**.”

Sources:
*http://www.ilsd.uscourts.gov/mdl/mdl2385.aspx
**http://www.ilsd.uscourts.gov/Documents/mdl2385/cmo17.pdf

If you believe that you or one of your loved ones has been injured by Pradaxa, you may want to speak with a personal injury lawyer regarding a dangerous drug claim. A Pradaxa lawyer familiar with new developments in the investigation of the drug Pradaxa may be able to help you make important personal and legal decisions. d'Oliveira & Associates, P.C. is working with some of the leading Pradaxa lawyers and dangerous drug attorneys in the country who are handling these cases.

Please contact the law offices of d'Oliveira & Associates, P.C at 1-800-992-6878 or fill out a contact form for a free legal consultation.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10418353.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. d’Oliveira & Associates Issues Webpage With Current Information On Stryker Hip Implant Lawsuits
2. d’Oliveira & Associates Releases Webpage With Current Information on Fresenius Lawsuits
3. d’Oliveira & Associates Releases Mirena IUD Infographic Describing Bayer’s Deceptive Mirena Simple Style Campaign
4. d’Oliveira & Associates Issues Webpage With Current Information On Mirena IUD Lawsuits
5. Research shows efficacy of treatment model developed at Women & Infants
6. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
7. Vendors in Nevada, Michigan, & Illinois to be Featured on the PartyPOP.com Online Network
8. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
9. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
10. Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
11. Play & Park Structures Included in New Play for All Abilities Playground
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: